Gilead Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gilead Sciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $1.90 | $1.70 | 11.8 % |
Q3 | 2024-11-06 | $2.02 | $1.55 | 30.3 % |
Q2 | 2024-08-08 | $2.01 | $1.60 | 25.6 % |
Q1 | 2024-04-25 | $-1.32 | $-1.49 | 11.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $7.57B | $7.15B | 5.86 % |
Q3 | 2024-11-06 | $7.55B | $7.00B | 7.79 % |
Q2 | 2024-08-08 | $6.95B | $6.72B | 3.48 % |
Q1 | 2024-04-25 | $6.69B | $6.34B | 5.46 % |
Gilead Sciences (GILD) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
The Actual EPS was $1.90, which beat the estimate of $1.70.
The Actual Revenue was $7.6B, which beat the estimate of $7.2B.
Browse earnings estimates, EPS, and revenue on all stocks.